IBDEI0PW ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11641,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Acute
 ;;^UTILITY(U,$J,358.3,11641,1,4,0)
 ;;=4^N00.9
 ;;^UTILITY(U,$J,358.3,11641,2)
 ;;=^5015500
 ;;^UTILITY(U,$J,358.3,11642,0)
 ;;=N08.^^46^565^2
 ;;^UTILITY(U,$J,358.3,11642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11642,1,3,0)
 ;;=3^Glomerular Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,11642,1,4,0)
 ;;=4^N08.
 ;;^UTILITY(U,$J,358.3,11642,2)
 ;;=^5015569
 ;;^UTILITY(U,$J,358.3,11643,0)
 ;;=N03.9^^46^565^4
 ;;^UTILITY(U,$J,358.3,11643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11643,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Chronic
 ;;^UTILITY(U,$J,358.3,11643,1,4,0)
 ;;=4^N03.9
 ;;^UTILITY(U,$J,358.3,11643,2)
 ;;=^5015530
 ;;^UTILITY(U,$J,358.3,11644,0)
 ;;=N05.8^^46^566^1
 ;;^UTILITY(U,$J,358.3,11644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11644,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
 ;;^UTILITY(U,$J,358.3,11644,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,11644,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,11645,0)
 ;;=M30.0^^46^567^2
 ;;^UTILITY(U,$J,358.3,11645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11645,1,3,0)
 ;;=3^Polyarteritis Nodosa
 ;;^UTILITY(U,$J,358.3,11645,1,4,0)
 ;;=4^M30.0
 ;;^UTILITY(U,$J,358.3,11645,2)
 ;;=^5011738
 ;;^UTILITY(U,$J,358.3,11646,0)
 ;;=N04.9^^46^567^1
 ;;^UTILITY(U,$J,358.3,11646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11646,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Morphologic Changes
 ;;^UTILITY(U,$J,358.3,11646,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,11646,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,11647,0)
 ;;=N13.30^^46^568^2
 ;;^UTILITY(U,$J,358.3,11647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11647,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,11647,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,11647,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,11648,0)
 ;;=N13.9^^46^568^12
 ;;^UTILITY(U,$J,358.3,11648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11648,1,3,0)
 ;;=3^Uropathy,Obstructive & Reflux,Unspec
 ;;^UTILITY(U,$J,358.3,11648,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,11648,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,11649,0)
 ;;=N40.1^^46^568^1
 ;;^UTILITY(U,$J,358.3,11649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11649,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,11649,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,11649,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,11650,0)
 ;;=R39.14^^46^568^3
 ;;^UTILITY(U,$J,358.3,11650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11650,1,3,0)
 ;;=3^Incomplete Bladder Emptying
 ;;^UTILITY(U,$J,358.3,11650,1,4,0)
 ;;=4^R39.14
 ;;^UTILITY(U,$J,358.3,11650,2)
 ;;=^5019344
 ;;^UTILITY(U,$J,358.3,11651,0)
 ;;=R35.1^^46^568^4
 ;;^UTILITY(U,$J,358.3,11651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11651,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,11651,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,11651,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,11652,0)
 ;;=R39.16^^46^568^5
 ;;^UTILITY(U,$J,358.3,11652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11652,1,3,0)
 ;;=3^Straining on Urinartion
 ;;^UTILITY(U,$J,358.3,11652,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,11652,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,11653,0)
 ;;=R35.0^^46^568^6
 ;;^UTILITY(U,$J,358.3,11653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11653,1,3,0)
 ;;=3^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,11653,1,4,0)
 ;;=4^R35.0
